Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-05-005655
Filing Date
2005-02-11
Accepted
2005-02-11 13:24:56
Documents
1
Period of Report
2005-02-09

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 2964
  Complete submission text file 0001104659-05-005655.txt   4789
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Issuer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 0907
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1110 N. LAKESHORE DRIVE, APT. 33N CHICAGO IL 60611
Business Address 312-642-0570
Eidell Ronald G (Reporting) CIK: 0001308803 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12493 | Film No.: 05596788